Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05974150 · ClinicalTrials.gov registry record
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
A clinical trial of Breast Cancer and Multiple Myeloma, sponsored by Carevive Systems.
- Recruiting
- Registry status
- 25
- Enrollment target
- 7
- Study locations
NCT05974150 is a study of Breast Cancer and Multiple Myeloma that is actively recruiting participants, run by Carevive Systems. The registered enrollment target is 25 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 4 states.
The verdict
NCT05974150, a study of Breast Cancer and Multiple Myeloma, is actively recruiting participants, sponsored by Carevive Systems.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 7
- Study locations
Study Summary
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
Conditions Studied
Interventions
- OTHER Web based survey
Study Locations (7)
Ohio
- Cleveland Clinic Mercy Hospital - Canton
- University Hospitals Seidman Cancer Center - Cleveland
- Tri-County Hematology & Oncology Associates, Inc. - Massillon
North Carolina
- Univeristy of North Carolina at Chapel Hill - Chapel Hill
- Duke - Durham
Connecticut
- Yale Cancer Center - New Haven
Illinois
- Northshore University Health System - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-07-19 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05974150
The ClinicalTrials.gov registry entry for NCT05974150 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Carevive Systems, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Web based survey is the first listed.
NCT05974150 reports 7 study locations spanning 4 distinct geographic areas - top geographies include Ohio, North Carolina, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05974150 about?
NCT05974150 is a clinical study titled "Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring". The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will...
What is the current status of trial NCT05974150?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2023-07-19. Estimated completion is 2026-12-31.
What conditions does trial NCT05974150 study?
This clinical trial studies the following conditions: Breast Cancer, Multiple Myeloma, Lung Cancer, Ovarian Cancer, Acute Myelogenous Leukemia.
What interventions are being tested in trial NCT05974150?
The interventions under investigation include: Web based survey (OTHER).
Who is sponsoring clinical trial NCT05974150?
This trial is sponsored by Carevive Systems, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05974150 being conducted?
This trial has 7 study locations across Connecticut, Illinois, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.